Featured
Early-phase Drugs in Development for Dry AMD
Promising candidates are numerous.
By William Carrera, MD, MS, Roger A. Goldberg, MD, MBA
Complications of Intravitreal Injections
Incidence is low, but caution is warranted.
By Efrat Fleissig, MD, Anat Loewenstein, MD, MHA
Treating AMD at the Intermediate Level
Several therapies are under study to treat this elusive pathology.
By Carla Danese, MD, PAOLO LANZETTA, MD
Photobiomodulation as an Innovative and Promising Treatment for Retinal Disease
Evidence supports its use in ocular disease.
By Marion R. Munk, MD, PhD, FEBO, Krisztina Valter, MD, PhD
The Current Landscape of Intravitreal Treatments for Neovascular AMD
New drugs and devices help patients to receive personalized treatments.
By Matias Iglicki, MD, Anat Loewenstein, MD, MHA, Dinah Zur, MD
Web Exclusives
Interpretation of Roth-like Spots
Retinal findings are a window into systemic health.
By Diana Driscoll, OD, David Callanan, MD
Departments
UPFRONT: Medical Therapy in a Time of War
By Peter K. Kaiser, MD
CONTROVERSIES IN CARE: Workup of Acute Retinal Artery Occlusion
Should it be done in the outpatient or inpatient setting?
By Michael Colucciello, MD, Timothy W. Olsen, MD, Kamal Kishore, MD, FASRS
CLINICAL TRIAL DOWNLOAD: Update on Advances Toward Therapeutics in Inherited Retinal Dystrophies
The past decade has seen many new developments.
By Yasha Modi, MD , Peter Y. Zhao, MD, Thiran Jayasundera, MD, MS
CODING Q&A: Coding Changes in 2022
Two codes see changes to their global periods, plus physician reimbursement.
By Suzanne L. Corcoran, COE
NEW PRODUCT APPLICATIONS: Eidon Lens Provides a Panoramic View of the Retina
Ultrawidefield accessory enables 200-degree images.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: FDA approves uveal melanoma treatment, sepofarsen fails to meet endpoints, and more.
By Rochelle Nataloni, contributing writer